211 related articles for article (PubMed ID: 2318950)
1. Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism.
Tohme JF; Bilezikian JP; Clemens TL; Silverberg SJ; Shane E; Lindsay R
J Clin Endocrinol Metab; 1990 Apr; 70(4):951-6. PubMed ID: 2318950
[TBL] [Abstract][Full Text] [Related]
2. Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro.
el-Hajj Fuleihan G; Chen CJ; Rivkees SA; Marynick SP; Stock J; Pallotta JA; Brown EM
J Clin Endocrinol Metab; 1989 Oct; 69(4):860-7. PubMed ID: 2778039
[TBL] [Abstract][Full Text] [Related]
3. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
6. Suppression by calcium of serum levels of intact parathyroid hormone in patients with primary hyperparathyroidism.
Bergenfelz A; Valdermarsson S; Ahrén B
Horm Res; 1993; 39(3-4):146-51. PubMed ID: 8262476
[TBL] [Abstract][Full Text] [Related]
7. Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.
Ahrén B; Bergenfelz A
Horm Res; 1995; 43(6):294-9. PubMed ID: 7607615
[TBL] [Abstract][Full Text] [Related]
8. Functional recovery of the parathyroid glands after surgery for primary hyperparathyroidism.
Bergenfelz A; Valdermarsson S; Ahrén B
Surgery; 1994 Nov; 116(5):827-36. PubMed ID: 7940185
[TBL] [Abstract][Full Text] [Related]
9. Suppressibility of serum levels of PTH by calcium in the immediate postoperative period after surgery for primary hyperparathyroidism.
Bergenfelz A; Ahrén B
World J Surg; 1993; 17(6):806-10. PubMed ID: 8109123
[TBL] [Abstract][Full Text] [Related]
10. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H
J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032
[TBL] [Abstract][Full Text] [Related]
11. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
[TBL] [Abstract][Full Text] [Related]
12. Lack of influence of recombinant human erythropoietin on parathyroid function in hemodialysis patients with secondary hyperparathyroidism.
Lai YH; Tsai JC; Chen HC; Guh JY; Hwang SJ; Tsai JH
Nephron; 1995; 70(2):223-8. PubMed ID: 7566308
[TBL] [Abstract][Full Text] [Related]
13. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
[TBL] [Abstract][Full Text] [Related]
14. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism.
Shoback DM; Bilezikian JP; Turner SA; McCary LC; Guo MD; Peacock M
J Clin Endocrinol Metab; 2003 Dec; 88(12):5644-9. PubMed ID: 14671147
[TBL] [Abstract][Full Text] [Related]
15. Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study.
Schwarz P; Sørensen HA; Momsen G; McNair P; Transbøl I
Clin Endocrinol (Oxf); 1992 Oct; 37(4):344-8. PubMed ID: 1483290
[TBL] [Abstract][Full Text] [Related]
16. Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).
Sørensen HA; Schwarz P; Hyldstrup L; Transbøl I
Clin Endocrinol (Oxf); 1994 Mar; 40(3):309-15. PubMed ID: 8187293
[TBL] [Abstract][Full Text] [Related]
17. Influence of vitamin D on parathyroid function in the elderly.
Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
[TBL] [Abstract][Full Text] [Related]
18. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism.
Ljunghall S; Larsson K; Lindh E; Lindqvist U; Rastad J; Akerström G; Wide L
Surgery; 1991 Jul; 110(1):47-53. PubMed ID: 1907770
[TBL] [Abstract][Full Text] [Related]
19. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
[TBL] [Abstract][Full Text] [Related]
20. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
